Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

 
• By Cathy Kelly
Medicare is the lead US payer for Alzheimer's drugs. • Source: Shutterstock

More from Market Access

More from Pink Sheet